The World Health Organization (WHO) has asked for menstruation health to be recognized, defined, and handled as a health issue rather than a hygiene one, claiming that many Nigerian women suffer in silence.
Following suit, Immunotherapy Nigeria Limited introduced immunocal, a bioactive biomolecules product that has dramatically improved women’s health around the world, most notably in Nigeria.
Immunocal is a novel type of immunotherapy that provides the molecules required by the body to repair a wide range of damaged cells, resulting in hormone balance for men and women, improved menstrual health for women, effective control of autoimmune conditions, and effective treatment of resistant infectious diseases, among many other benefits.
In a statement, Lawrence Olagunju, the founder and CEO of Immunotherapy Nigeria Ltd, said, “Immunocal is the only product with the ability to effect the three most critical elements of health simultaneously.”
Olagunju revealed that after more than 40 years of research, Canadian scientists discovered, separated, and packaged Immunocal, the potent healing properties found only in Mother’s Milk. “This is a one-of-a-kind formulation of 28 bioactive biomolecules that has been shown to repair damaged womb and ovaries cells, restore normal, pain-free period flow, and achieve good ovulation, with the potential of achieving pregnancy sooner in pregnancy-challenged women.”
Olagunju explained that Immunocal has the ability to provide the complete nine essential and 11 non-essential amino acids, the building blocks for the body to make over 1,000 proteins required for body functions, and that modulation of the three most important biosynthesis has been the key to its overwhelming importance.
Adesoji Fasanmade, a Professor of Medicine at the University of Ibadan and consultant physician at the University College Hospital, Ibadan, said of the randomised use of Immunocal treatment-related reactions, “I am delighted that Immunocal is a proven standard of care for body cell repairs and provides a significant improvement in survival for patients with diseases.”
“I can attest that we give the product to a large number of my patients.” We provide it to people who have diabetes, hypertension, or other conditions that may weaken the patient’s immunity. “Adding Immunocal to such patients’ basic treatment makes them more able to condense the effect of the sickness and heal faster,” he explained.
